Plain-English translation of NCT06527547 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing transcutaneous auricular vagus nerve stimulation (taVNS)—a non-invasive treatment that delivers gentle electrical pulses to specific points on your ear. The goal is to see if this treatment can improve sleep quality in people with rheumatoid arthritis, compared to a placebo device that looks the same but doesn't deliver real stimulation.
Many people with rheumatoid arthritis struggle with sleep problems, which can make their condition worse and affect their quality of life. Researchers want to find a safe, non-drug treatment option that could help without the side effects of sleeping pills.
You will use a small electrical stimulation device on your ear at home for 4 weeks, with treatment sessions twice daily for 30 minutes each, five days a week. You'll keep a daily sleep diary and visit the hospital once a week for check-ups and tests. Half of participants will receive the real treatment, and half will receive a placebo device that looks identical but doesn't deliver stimulation.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
China